See more : Venlon Enterprises Limited (VENLONENT.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Berkeley Lights, Inc. (BLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Berkeley Lights, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- ArriVent BioPharma, Inc. Common Stock (AVBP) Income Statement Analysis – Financial Results
- Veea Inc. (VEEA) Income Statement Analysis – Financial Results
- The Music Acquisition Corporati (TMAC-WT) Income Statement Analysis – Financial Results
- Shinwa Wise Holdings Co.,Ltd. (2437.T) Income Statement Analysis – Financial Results
- Xingye Wulian Service Group Co. Ltd. (9916.HK) Income Statement Analysis – Financial Results
Berkeley Lights, Inc. (BLI)
About Berkeley Lights, Inc.
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Revenue | 78.60M | 85.39M | 64.30M | 56.69M | 31.30M |
Cost of Revenue | 24.81M | 28.84M | 19.75M | 13.22M | 8.18M |
Gross Profit | 53.78M | 56.55M | 44.56M | 43.48M | 23.12M |
Gross Profit Ratio | 68.43% | 66.23% | 69.29% | 76.69% | 73.86% |
Research & Development | 53.21M | 58.55M | 47.24M | 38.41M | 29.08M |
General & Administrative | 0.00 | 43.40M | 23.20M | 12.36M | 9.07M |
Selling & Marketing | 0.00 | 25.39M | 14.51M | 9.24M | 6.13M |
SG&A | 95.12M | 68.79M | 37.71M | 21.60M | 15.20M |
Other Expenses | -246.00K | 6.00K | 82.00K | -1.18M | 0.00 |
Operating Expenses | 148.32M | 127.34M | 84.95M | 60.01M | 44.28M |
Cost & Expenses | 173.14M | 156.18M | 104.70M | 73.23M | 52.46M |
Interest Income | 1.27M | 175.00K | 338.00K | 909.00K | 872.00K |
Interest Expense | 910.00K | 1.17M | 1.44M | 1.43M | 2.20M |
Depreciation & Amortization | 1.02M | 181.00K | 420.00K | 6.24M | 4.29M |
EBITDA | -93.52M | -70.61M | -39.97M | -10.29M | -16.87M |
EBITDA Ratio | -118.99% | -82.69% | -62.17% | -18.16% | -53.89% |
Operating Income | -94.54M | -70.79M | -40.39M | -16.54M | -21.16M |
Operating Income Ratio | -120.29% | -82.90% | -62.82% | -29.17% | -67.60% |
Total Other Income/Expenses | -3.40M | -990.00K | -1.02M | -1.70M | -2.11M |
Income Before Tax | -97.94M | -71.78M | -41.41M | -18.23M | -23.27M |
Income Before Tax Ratio | -124.61% | -84.06% | -64.40% | -32.16% | -74.34% |
Income Tax Expense | 100.00K | -55.00K | 174.00K | 69.00K | 69.00K |
Net Income | -98.04M | -71.72M | -41.58M | -18.30M | -23.34M |
Net Income Ratio | -124.74% | -84.00% | -64.67% | -32.28% | -74.56% |
EPS | -1.42 | -1.08 | -1.33 | -0.34 | -0.44 |
EPS Diluted | -1.42 | -1.08 | -1.33 | -0.34 | -0.44 |
Weighted Avg Shares Out | 68.87M | 66.71M | 31.19M | 53.51M | 53.51M |
Weighted Avg Shares Out (Dil) | 68.87M | 66.71M | 31.19M | 53.51M | 53.51M |
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Berkeley Lights, Inc. Investors to Secure Counsel Before Important February 7 Deadline in Securities Class Action - BLI
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Berkeley Lights, Inc. Shareholders of Securities Fraud Class Action Lawsuit
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Berkeley Lights, Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 7, 2022 - BLI
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Berkeley Lights, Inc. (BLI) Investors
BLI DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 7, 2022 Deadline Reminder for Berkeley Lights, Inc.
Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service
ROSEN, LEADING INVESTOR COUNSEL, Encourages Berkeley Lights, Inc. Investors with Losses to Secure Counsel Before Important February 7 Deadline in Securities Class Action - BLI
Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Berkeley Lights, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Berkeley Lights, Inc. Investors to Secure Counsel Before Important February 7 Deadline in Securities Class Action - BLI
Investor Action Notice: The Schall Law Firm Encourages Investors In Berkeley Lights, Inc. With Losses Of $100,000 To Contact The Firm
Source: https://incomestatements.info
Category: Stock Reports